SCHEMBL973761

SCHEMBL973761

CC(=O)Nc1cc(N)ccc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 4/20 0.52
MAPT P10636 3/20 0.52
CYP3A4 P08684 2/20 0.52
GAA P10253 2/20 0.52
ESR2 Q92731 1/20 0.52
PTPN1 P18031 1/20 0.52
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
THRB P10828 2/20 0.47
RECQL P46063 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
POLB P06746 2/20 0.47
CYP2C19 P33261 2/20 0.47
USP2 O75604 1/20 0.47
PKM P14618 1/20 0.47
APEX1 P27695 1/20 0.47
BLM P54132 1/20 0.47
MCL1 Q07820 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5098575 0.86 KDM4E (0.65) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL5151899 0.83 GAA (0.60) ALDH1A1KDM4EMAPTGAAHSD17B10
SCHEMBL10935269 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL13178173 0.81 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL8966015 0.81 NPC1 (0.54) ALDH1A1KDM4EMAPTGAAHSD17B10
SCHEMBL14075166 0.81 MAPT (0.57) ALDH1A1KDM4EMAPTCYP3A4GAA
SCHEMBL6891543 0.80 KMT2A (0.55) ALDH1A1KDM4EGAAHSD17B10MEN1
SCHEMBL976774 0.80 MPO (0.58) ALDH1A1KDM4EMAPTHSD17B10MEN1
SCHEMBL5490228 0.80 KDM4E (0.57) ALDH1A1KDM4EMAPTCYP3A4HSD17B10
SCHEMBL1304624 0.80 NEU3 (0.54) ALDH1A1KDM4EMAPTHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200093817-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE ELYSIUM THERAPEUTICS, INC. 2020-03-26 US claimed
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE ELYSIUM THERAPEUTICS, INC. 2018-03-29 US claimed
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US claimed
EP-3226907-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF Kempharm, Inc. (US) 2017-10-11 EP claimed
EP-3223819-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE Kempharm, Inc. (US) 2017-10-04 EP claimed
US-20160168160-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2016-06-16 US claimed
WO-2016089951-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF KEMPHARM, INC. (US) 2016-06-09 WO claimed
US-20160151352-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2016-06-02 US claimed
WO-2016086113-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE KEMPHARM, INC. (US) 2016-06-02 WO claimed
EP-2771002-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2014-09-03 EP claimed
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-06-13 US claimed
WO-2013063204-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-05-02 WO claimed
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof ALTER DOMUS (US) LLC 2012-06-07 US claimed
CN-102480959-A Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof KEMPHARM INC 2012-05-30 CN claimed
EP-2448407-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2012-05-09 EP claimed
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2011-01-06 US claimed
US-12590065-B2 Levorphanol prodrugs and processes for making and using them ZEVRA THERAPEUTICS, INC. (US) 2026-03-31 US disclosed
US-20250161468-A1 POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE ELYSIUM THERAPEUTICS, INC. 2025-05-22 US disclosed
EP-0038453-A2 Process for the preparation of water soluble phthalocyanine dyestuffs BAYER AG (DE) 1981-10-28 EP disclosed
US-4268267-A PRINTING AND DYEING TEXTILES BAYER AKTIENGESELLSCHAFT (DE) 1981-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200093817-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE OPRM1, OPRK1, OPRD1 ALDH1A1 383/4885KDM4E 1535/4885MAPT 922/4885
US-20180085366-A1 OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE OPRM1, OPRK1, OPRD1 ALDH1A1 383/4885KDM4E 1535/4885MAPT 922/4885
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 ALDH1A1 125/4885KDM4E 2523/4885MAPT 2959/4885
US-20160151352-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 ALDH1A1 125/4885KDM4E 2523/4885MAPT 2959/4885
US-12590065-B2 Levorphanol prodrugs and processes for making and using them SLC16A3, SLC16A8, SLC16A1 ALDH1A1 716/4885KDM4E 1294/4885MAPT 2316/4885
US-20160168160-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 ALDH1A1 217/4885KDM4E 1553/4885MAPT 2924/4885
US-20250161468-A1 POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE OPRM1, OPRK1, OPRL1 ALDH1A1 292/4885KDM4E 1929/4885MAPT 2373/4885
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF CYP2B6, CYP3A43, CYP2D6 ALDH1A1 160/4885KDM4E 1802/4885MAPT 2405/4885
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof CYP2B6, CYP3A43, CYP2D6 ALDH1A1 160/4885KDM4E 1802/4885MAPT 2405/4885
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, CYP2D6 ALDH1A1 92/4885KDM4E 3324/4885MAPT 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.